Mirae Asset Global Investments
ADMA icon

Mirae Asset Global Investments’s ADMA Biologics ADMA Stock Holding History

Mirae Asset Global Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.8K Sell
10,366
-2,177
-17% -$19.8K ﹤0.01% 1265
2026
Q1 		$113K Buy
12,543
+978
+8% +$15.4K ﹤0.01% 1159
2025
Q4 		$211K Buy
11,565
+2,339
+25% +$39.4K ﹤0.01% 1137
2025
Q3 		$135K Buy
9,226
+4
+0% +$69 ﹤0.01% 1168
2025
Q2 		$168K Buy
9,222
+1,312
+17% +$26.8K ﹤0.01% 1067
2025
Q1 		$160K Buy
7,910
+33
+0.4% +$571 ﹤0.01% 1077
2024
Q4 		$137K Sell
7,877
-553
-7% -$10.4K ﹤0.01% 1104
2024
Q3 		$163K Buy
8,430
+1,509
+22% +$23.5K ﹤0.01% 1121
2024
Q2 		$75.8K Sell
6,921
-20,467
-75% -$172K ﹤0.01% 1180
2024
Q1 		$181K Sell
27,388
-87,993
-76% -$481K ﹤0.01% 2286
2023
Q4 		$522K Sell
115,381
-1,222
-1% -$4.52K ﹤0.01% 1945
2023
Q3 		$417K Sell
116,603
-4,189
-3% -$16.1K ﹤0.01% 1975
2023
Q2 		$444K Buy
120,792
+78,169
+183% +$290K ﹤0.01% 1997
2023
Q1 		$141K Buy
+42,623
New +$147K ﹤0.01% 2395

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's ADMA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its ADMA Biologics (ADMA) stake by 17% in Q2 2026, selling an estimated $19.8K and leaving 10,366 shares worth $86.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

Mirae Asset Global Investments first reported a position in ADMA in Q1 2023 and has held it in 14 quarters since. The position peaked at $522K in Q4 2023. 131 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Mirae Asset Global Investments held 10,366 shares of ADMA Biologics worth $86.8K as of Q2 2026.
  • Mirae Asset Global Investments sold 2,177 ADMA Biologics shares in Q2 2026, an estimated $19.8K.
  • ADMA Biologics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1265 holding.
  • Mirae Asset Global Investments first reported a position in ADMA Biologics in Q1 2023 and has held it in 14 quarters since.
  • Mirae Asset Global Investments's ADMA Biologics position peaked at $522K in Q4 2023.
  • 131 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.